blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2244708

EP2244708 - NEW 2,3,4,5-TETRAHYDRO-1H-PYRIDO[4,3-B]INDOLE COMPOUNDS AND METHODS OF USE THEREOF [Right-click to bookmark this link]
Former [2010/44]NEW 2,3,4,5-TEtRAHYDRO-1H-PYRIDO [4,3-B] INDOLE COMPOUNDS AND METHODS OF USE THEREOF
[2014/33]
StatusNo opposition filed within time limit
Status updated on  20.11.2015
Database last updated on 16.07.2024
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK		published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
Medivation Technologies, Inc.
525 Market Street, 36th Floor
San Francisco, CA 94105 / US
[2013/32]
Former [2010/44]For all designated states
Medivation Technologies, Inc.
201 Spear Street, 3rd Floor
San Francisco, CA 94105 / US
Inventor(s)01 / HUNG, David, T.
36 Loma Road
Redwood City CA 94062 / US
02 / PROTTER, Andrew, Asher
185 North California Avenue
Palo Alto CA 94301 / US
03 / CHAKRAVARTY, Sarvajit
1888 Miramonte Avenue
Mountain View CA 94040 / US
04 / JAIN, Rajendra, Parasmal
E-202, Sapphire Park
Park Street Phase II
Wakad, Pune
Maharashtra 411 057 / IN
 [2015/03]
Former [2010/44]01 / HUNG, David, T.
36 Loma Road
Redwood City CA 94062 / US
02 / PROTTER, Andrew, Asher
185 North California Avenue
Palo Alto CA 94301 / US
03 / CHAKRAVARTY, Sarvajit
1888 Miramonte Avenue
Mountain View CA 94040 / US
04 / JAIN, Rajendra, Parasmal
E-202, Sapphire Park Park Street Phase II Wakad, Pune
Maharashtra 411 057 / IN
Representative(s)Sexton, Jane Helen, et al
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[2015/03]
Former [2010/44]Sexton, Jane Helen, et al
J.A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5JJ / GB
Application number, filing date09704753.426.01.2009
[2010/44]
WO2009US32065
Priority number, dateUS2008006243025.01.2008         Original published format: US 62430
RU2008010299325.01.2008         Original published format: RU 2008102993
US2008006239425.01.2008         Original published format: US 62394
[2010/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009094668
Date:30.07.2009
Language:EN
[2009/31]
Type: A1 Application with search report 
No.:EP2244708
Date:03.11.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 30.07.2009 takes the place of the publication of the European patent application.
[2010/44]
Type: B1 Patent specification 
No.:EP2244708
Date:14.01.2015
Language:EN
[2015/03]
Search report(s)International search report - published on:US30.07.2009
(Supplementary) European search report - dispatched on:EP06.12.2011
ClassificationIPC:A61K31/4745, C07D471/02
[2010/44]
CPC:
C07D487/14 (EP,US); A61P17/14 (EP); A61P21/00 (EP);
A61P21/02 (EP); A61P21/04 (EP); A61P25/00 (EP);
A61P25/02 (EP); A61P25/14 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/22 (EP); A61P25/24 (EP);
A61P25/28 (EP); A61P27/02 (EP); A61P3/10 (EP);
A61P31/22 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P9/10 (EP); C07D471/04 (EP,US); C07D471/14 (EP,US);
C07D487/04 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/44]
TitleGerman:NEUE 2,3,4,5-TETRAHYDRO-1H-PYRIDO[4,3-B]INDOL-VERBINDUNGEN UND VERFAHREN ZUR VERWENDUNG DAVON[2014/33]
English:NEW 2,3,4,5-TETRAHYDRO-1H-PYRIDO[4,3-B]INDOLE COMPOUNDS AND METHODS OF USE THEREOF[2014/33]
French:COMPOSÉS INÉDITS DE 2,3,4,5-TÉTRAHYDRO-1H-PYRIDO[4,3-B]INDOLE ET LEURS PROCÉDÉS D'UTILISATION[2014/33]
Former [2010/44]NEUE 2,3,4,5-TETRAHYDRO-1H-PYRIDO [4,3-B] INDOL-VERBINDUNGEN UND VERFAHREN ZUR VERWENDUNG DAVON
Former [2010/44]NEW 2,3,4,5-TEtRAHYDRO-1H-PYRIDO [4,3-B] INDOLE COMPOUNDS AND METHODS OF USE THEREOF
Former [2010/44]COMPOSÉS INÉDITS DE 2,3,4,5-TÉTRAHYDRO-1H-PYRIDO [4,3-B] INDOLE ET LEURS PROCÉDÉS D'UTILISATION
Entry into regional phase17.08.2010National basic fee paid 
17.08.2010Search fee paid 
17.08.2010Designation fee(s) paid 
17.08.2010Examination fee paid 
Examination procedure17.08.2010Examination requested  [2010/44]
08.08.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
17.10.2012Amendment by applicant (claims and/or description)
06.12.2012Despatch of a communication from the examining division (Time limit: M06)
17.06.2013Reply to a communication from the examining division
01.07.2013Despatch of a communication from the examining division (Time limit: M02)
11.09.2013Reply to a communication from the examining division
14.03.2014Communication of intention to grant the patent
09.07.2014Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
14.08.2014Communication of intention to grant the patent
05.12.2014Fee for grant paid
05.12.2014Fee for publishing/printing paid
05.12.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.12.2012
Opposition(s)15.10.2015No opposition filed within time limit [2015/52]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
17.10.2012Request for further processing filed
17.10.2012Full payment received (date of receipt of payment)
Request granted
31.10.2012Decision despatched
Fees paidRenewal fee
22.06.2011Renewal fee patent year 03
09.01.2012Renewal fee patent year 04
08.01.2013Renewal fee patent year 05
31.01.2014Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.01.201103   M06   Fee paid on   22.06.2011
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU26.01.2009
AT14.01.2015
BE14.01.2015
CY14.01.2015
CZ14.01.2015
DK14.01.2015
EE14.01.2015
ES14.01.2015
FI14.01.2015
HR14.01.2015
IT14.01.2015
LT14.01.2015
LV14.01.2015
MC14.01.2015
MK14.01.2015
MT14.01.2015
NL14.01.2015
PL14.01.2015
RO14.01.2015
SE14.01.2015
SI14.01.2015
SK14.01.2015
TR14.01.2015
IE26.01.2015
LU26.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
PT14.05.2015
[2018/30]
Former [2018/02]HU26.01.2009
AT14.01.2015
BE14.01.2015
CY14.01.2015
CZ14.01.2015
DK14.01.2015
EE14.01.2015
ES14.01.2015
FI14.01.2015
HR14.01.2015
IT14.01.2015
LT14.01.2015
LV14.01.2015
MC14.01.2015
MT14.01.2015
NL14.01.2015
PL14.01.2015
RO14.01.2015
SE14.01.2015
SI14.01.2015
SK14.01.2015
TR14.01.2015
IE26.01.2015
LU26.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
PT14.05.2015
Former [2017/40]HU26.01.2009
AT14.01.2015
BE14.01.2015
CY14.01.2015
CZ14.01.2015
DK14.01.2015
EE14.01.2015
ES14.01.2015
FI14.01.2015
HR14.01.2015
IT14.01.2015
LT14.01.2015
LV14.01.2015
MC14.01.2015
MT14.01.2015
NL14.01.2015
PL14.01.2015
RO14.01.2015
SE14.01.2015
SI14.01.2015
SK14.01.2015
TR14.01.2015
IE26.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
PT14.05.2015
Former [2017/03]AT14.01.2015
BE14.01.2015
CZ14.01.2015
DK14.01.2015
EE14.01.2015
ES14.01.2015
FI14.01.2015
HR14.01.2015
IT14.01.2015
LT14.01.2015
LV14.01.2015
MC14.01.2015
MT14.01.2015
NL14.01.2015
PL14.01.2015
RO14.01.2015
SE14.01.2015
SI14.01.2015
SK14.01.2015
IE26.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
Former [2016/24]AT14.01.2015
BE14.01.2015
CZ14.01.2015
DK14.01.2015
EE14.01.2015
ES14.01.2015
FI14.01.2015
HR14.01.2015
IT14.01.2015
LT14.01.2015
LV14.01.2015
MC14.01.2015
NL14.01.2015
PL14.01.2015
RO14.01.2015
SE14.01.2015
SI14.01.2015
SK14.01.2015
IE26.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
Former [2016/12]AT14.01.2015
CZ14.01.2015
DK14.01.2015
EE14.01.2015
ES14.01.2015
FI14.01.2015
HR14.01.2015
IT14.01.2015
LT14.01.2015
LV14.01.2015
MC14.01.2015
NL14.01.2015
PL14.01.2015
RO14.01.2015
SE14.01.2015
SI14.01.2015
SK14.01.2015
IE26.01.2015
BE31.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
Former [2016/07]AT14.01.2015
CZ14.01.2015
DK14.01.2015
EE14.01.2015
ES14.01.2015
FI14.01.2015
HR14.01.2015
IT14.01.2015
LT14.01.2015
LV14.01.2015
MC14.01.2015
NL14.01.2015
PL14.01.2015
RO14.01.2015
SE14.01.2015
SK14.01.2015
IE26.01.2015
BE31.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
Former [2016/03]AT14.01.2015
CZ14.01.2015
DK14.01.2015
EE14.01.2015
ES14.01.2015
FI14.01.2015
HR14.01.2015
IT14.01.2015
LT14.01.2015
LV14.01.2015
MC14.01.2015
NL14.01.2015
PL14.01.2015
RO14.01.2015
SE14.01.2015
SK14.01.2015
BE31.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
Former [2015/49]AT14.01.2015
CZ14.01.2015
DK14.01.2015
EE14.01.2015
ES14.01.2015
FI14.01.2015
HR14.01.2015
LT14.01.2015
LV14.01.2015
MC14.01.2015
NL14.01.2015
PL14.01.2015
RO14.01.2015
SE14.01.2015
SK14.01.2015
BE31.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
Former [2015/46]AT14.01.2015
ES14.01.2015
FI14.01.2015
HR14.01.2015
LT14.01.2015
LV14.01.2015
MC14.01.2015
NL14.01.2015
PL14.01.2015
SE14.01.2015
BE31.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
Former [2015/39]AT14.01.2015
ES14.01.2015
FI14.01.2015
HR14.01.2015
LT14.01.2015
LV14.01.2015
NL14.01.2015
PL14.01.2015
SE14.01.2015
BE31.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
Former [2015/38]AT14.01.2015
ES14.01.2015
FI14.01.2015
HR14.01.2015
LT14.01.2015
PL14.01.2015
SE14.01.2015
BE31.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
Former [2015/37]ES14.01.2015
FI14.01.2015
HR14.01.2015
LT14.01.2015
PL14.01.2015
SE14.01.2015
BE31.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
Former [2015/36]ES14.01.2015
FI14.01.2015
HR14.01.2015
LT14.01.2015
SE14.01.2015
BE31.01.2015
BG14.04.2015
NO14.04.2015
Former [2015/35]ES14.01.2015
LT14.01.2015
BE31.01.2015
NO14.04.2015
Former [2015/33]ES14.01.2015
BE31.01.2015
Former [2015/30]BE31.01.2015
Documents cited:Search[I]RU2140417  (INST FIZIOL AKTIVNYKH VESHCHES) [I] 1,16-18 * abstract * * tables 1,2; compounds 8,9,17,19,24,25 *;
 [A]WO03061657  (ARYX THERAPEUTICS [US], et al) [A] 1-18* the whole document *;
 [X]WO2006101434  (ASTRAZENECA AB [SE], et al) [X] 1,6,17,18 * examples 124-132; claims 9,10 *;
 [XP]WO2008115098  (ALLA CHEM LLC [US], et al) [XP] 1,16-18 * abstract * * compounds 1.1, 1.1.3-1.1.6, *;
 [XP]WO2009001129  (ASTRAZENECA AB [SE], et al) [XP] 1 * compounds 26,27 *
International search[Y]WO2007016353  (BRISTOL MYERS SQUIBB CO [US], et al);
 [Y]WO2007087425  (MEDIVATION INC [US], et al);
 [Y]  - SETOLA ET AL., "Molecular Determinants for the Interaction of the Valvulopathic Anorexigen Norfenfluramine with the 5-HT2B Receptor", MOL. PHARMACOLOGY, (200507), vol. 68, no. 1, pages 20 - 33, XP008139457

DOI:   http://dx.doi.org/10.1152/physiolgenomics.00158.2003
by applicantUS6187785
 US7071206
 WO2004US41081
 WO2006US39077
 WO2007US02117
 WO2007US20483
 WO2007US20516
 WO2007US22645
 WO2007US24626
 WO2007US24623
 WO2008US06667
 WO2008US08121
 WO2008US09357
 WO2008US77090
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.